Market Chatter: Lundbeck Said to Explore Potential Xeris Biopharma Acquisition

12:43 PM EDT, 09/29/2026 (MT Newswires) -- H Lundbeck has been working with advisers to explore acquiring Xeris Biopharma Holdings (XERS), Bloomberg reported Tuesday, citing people familiar with the matter. There's no guarantee that Lundbeck's interest will culminate in a deal for the commercial-stage drugmaker, the report said, citing the people. The companies didn't immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 10.19, Change: +0.36, Percent Change: +3.67